STOCK TITAN

Singularity Future Technology Ltd. 8-K Filings

SGLY NASDAQ

Every 8-K that Singularity Future Technology Ltd. (SGLY) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow SGLY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SGLY filings page.

Rhea-AI Summary

Singularity Future Technology Ltd. (SGLY) entered into two registered direct offerings of common stock and pre-funded warrants to raise new capital. In the first offering, the company agreed to sell 340,000 shares of common stock at $3.00 per share and pre-funded warrants to purchase 260,000 shares at $2.999 per warrant, with an exercise price of $0.001 per share, for gross proceeds of approximately $1.8 million before fees and expenses.

In the second offering, the company agreed to sell 451,250 shares of common stock at $3.20 per share and pre-funded warrants to purchase up to 1,111,250 shares at $3.199 per warrant, with a $0.001 exercise price, for gross proceeds of approximately $5.0 million. Net proceeds from the first offering are intended for working capital and general corporate purposes, while net proceeds from the second offering are intended for the planned data center business, working capital and general corporate purposes. Directors and officers entered into 90-day lock-up agreements, and the company agreed to certain 30-day restrictions on new issuances and registrations. Univest Securities LLC acted as exclusive placement agent, earning a 7% fee on gross proceeds and reimbursement of specified expenses, with a six-month right of first refusal.

Rhea-AI Summary

Singularity Future Technology Ltd. (SGLY) describes an amendment to a previously agreed private securities purchase transaction with eighteen non‑U.S. investors. The original June 19, 2025 agreement covered 2,299,212 post‑reverse‑split units, each consisting of one common share and three warrants, for approximately $30 million in gross proceeds under Regulation S.

On August 12, 2026, the company and the investors agreed that the warrants will be replaced by Amended and Restated Warrants, each exercisable for one common share at an exercise price of $0.001, with issuance expressly subject to shareholder approval. On the same date the company issued 2,299,212 common shares to the investors under Regulation S; the amended warrants will only be issued if the requisite shareholder approval is obtained.

Rhea-AI Summary

Singularity Future Technology Ltd. entered into a securities purchase agreement with certain investors on August 12, 2026. The company agrees to sell 21,520,803 shares of common stock at $1.394 per share in a private placement to investors who are “non-U.S. Persons” under Regulation S, for an aggregate purchase price of approximately $30 million.

The transaction is documented in a Securities Purchase Agreement containing customary representations, warranties, and covenants, including confirmations about investor status, absence of undisclosed material adverse effects, and certain legal proceedings disclosures. Closing is subject to specified conditions, including accuracy of representations and warranties and receipt of shareholder approval for the offering.

Rhea-AI Summary

Singularity Future Technology Ltd. reported that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a $1 minimum bid price for continued listing on The Nasdaq Capital Market. The company had previously fallen below this threshold for 30 consecutive business days and was given an initial 180-day compliance period to May 18, 2026, followed by an additional 180-day period to November 16, 2026.

On August 10, 2026, Nasdaq notified the company that it was back in compliance based on the closing bid price meeting the requirement for 10 consecutive business days from July 27, 2026 to August 7, 2026. Nasdaq has determined that the deficiency matter is now closed, and the company’s common stock remains listed on The Nasdaq Capital Market.

Rhea-AI Summary

Singularity Future Technology Ltd. is implementing a reverse stock split of its common stock at a 1-for-14 ratio, following prior shareholder approval and a board decision on July 7, 2026. Articles of Amendment filed in Virginia make the split effective at 12:01 a.m. ET on July 27, 2026.

Every fourteen shares will be combined into one, reducing issued and outstanding shares from 12,556,650 to 896,904, with fractional entitlements rounded up to the nearest whole share. Split-adjusted trading on The Nasdaq Capital Market under symbol SGLY, with new CUSIP 82935V406, is expected to begin on July 27, 2026.

Rhea-AI Summary

Singularity Future Technology Ltd. entered into a securities purchase agreement with certain non-U.S. investors to complete a private placement of 5,263,158 units at $0.38 per Unit, for aggregate gross proceeds of approximately $2,000,000.

Each Unit consists of one share of common stock and three Warrants, for a total of 15,789,474 Warrants. The Warrants are exercisable immediately at an initial exercise price of $0.418 per share, may be exercised cashlessly under specified conditions after one month, and expire five years from issuance. The transaction closed on July 13, 2026, and the shares were issued in reliance on Regulation S exemptions.

Rhea-AI Summary

Singularity Future Technology Ltd. entered into an Amended Settlement Agreement to resolve a pending federal securities class action for an aggregate cash settlement amount of $5,800,000, subject to Court approval. This includes $2,000,000 already in escrow, with $1,500,000 due within 15 days of execution and the remaining $2,300,000 due within 60 days after the initial payment. If payments are missed, plaintiffs may terminate the settlement and enforce a Confession of Judgment for the unpaid balance. The company states it admits no wrongdoing and views settlement as reducing litigation uncertainty and cost. At its June 30, 2026 annual meeting, shareholders re-elected two Class I directors, ratified Audit Alliance LLP, and approved the 2026 Incentive Plan, a Reverse Stock Split Amendment, and an Increase of Authorized Shares Amendment.

Rhea-AI Summary

Singularity Future Technology Ltd. received an additional 180-day extension from Nasdaq to regain compliance with the exchange’s $1.00 minimum bid price requirement for its common stock. The new compliance deadline is November 16, 2026, after the company did not regain compliance within the initial period ending May 18, 2026.

To cure the deficiency, the company’s closing bid price must be at or above $1.00 per share for at least ten consecutive business days before the new deadline. The company has told Nasdaq it may use a reverse stock split, if necessary, and plans to continue monitoring its share price. If it fails to regain compliance by the deadline, its securities may be subject to delisting, though it would have the right to appeal to a Nasdaq Hearings Panel.

Rhea-AI Summary

Singularity Future Technology Ltd. (SGLY) disclosed that it received a Nasdaq staff determination notice on November 19, 2025 stating that its common stock no longer meets the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market, after trading below that level for 30 consecutive business days. The notice does not immediately affect the stock’s listing. The company has an initial 180-day compliance period, until May 18, 2026, during which its closing bid price must be at or above $1.00 for at least ten consecutive business days to regain compliance.

If it does not regain compliance by that date, the company may qualify for an additional 180-day period if it meets other Nasdaq listing standards and notifies Nasdaq of its plan to cure the deficiency, which may include a reverse stock split. Failure to regain compliance could lead to a delisting determination, which the company would be able to appeal to a Nasdaq Hearings Panel. The company states that it intends to monitor its share price and may consider available options to meet Nasdaq’s bid price rule.

Rhea-AI Summary

Singularity Future Technology Ltd. (SGLY) reported shareholder voting results from a special meeting held on November 7, 2025 in Hong Kong. The company disclosed vote tallies for three matters. The first received 3,112,931 votes For, 28,075 Against, and 17,930 Abstain. The second received 3,108,709 For, 32,122 Against, and 18,106 Abstain. The third received 3,133,236 For, 6,920 Against, and 18,781 Abstain. These figures reflect the shareholders’ recorded votes on the matters presented.

Rhea-AI Summary

Singularity Future Technology (SGLY) announced board changes. On November 7, 2025, three directors—Ping Li, Mhlengi Prevail Mafu, and Lirong Huang—resigned from the company’s board, effective immediately. The company stated the resignations were not the result of any disagreement with the company on its operations, policies, or practices.

The filing focuses solely on these departures and the company’s confirmation that they were amicable in nature. It was signed by Chief Executive Officer Jia Yang. SGLY’s common stock continues to trade on The Nasdaq Stock Market under the symbol SGLY.

Rhea-AI Summary

Singularity Future Technology (SGLY) appointed three independent directors to its Board on October 29, 2025: Ping Li, Mhlengi Prevail Mafu, and Lirong Huang. Each will receive $24,000 in annual compensation under director offer letters.

The company states there are no family relationships with existing officers or directors, and no related-party transactions since the start of the last fiscal year, apart from the offer letters. A form of the Offer Letter was filed as Exhibit 10.1.

Rhea-AI Summary

Singularity Future Technology (SGLY) entered a securities purchase agreement to sell 3,000,000 shares of common stock at $0.70 per share in a private placement to non‑U.S. persons under Regulation S, for an aggregate purchase price of approximately $2.1 million.

The transaction closed on October 20, 2025 after closing conditions were met, and the shares were issued in reliance on Regulation S. The company currently intends to use the net proceeds for working capital and general corporate purposes.